Lung Cancer Home > Navelbine Chemotherapy Information

As a type of chemotherapy, Navelbine® (vinorelbine) is approved to treat non-small cell lung cancer in adults. It comes as an injection that is given intravenously (by IV) once a week. Side effects are common and may include nausea, anemia, and loss of strength.
If your healthcare provider recommends chemotherapy treatment with Navelbine, he or she will need information on your medical history and any other medications, vitamins, or supplements you are using. Reviewing these details can help reduce your risk for dangerous drug interactions or other potentially serious complications. For instance, Navelbine may not be safe for people who have nerve damage, low white blood cells, or problems with their liver or kidneys.
(For more information on this chemotherapy drug, click Navelbine. This full-length article includes details on how the medicine works, what to expect during treatment, and other important warnings and precautions.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.